Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.



Novel phosphine sulphide gold(i) complexes: topoisomerase I inhibitors and antiproliferative agents

Author affiliations

Abstract

This work describes the synthesis of the gold(I) complexes of phosphine sulphides. The formation of these new derivatives has been confirmed by X-ray crystallography. The coordination of gold(I) with the sulphur atom of the phosphine sulphides favors the inhibition of topoisomerase I as well as a high cytotoxicity of the gold(I)-complexed compounds against the cancer line A549 with IC50 values in the nanomolar range and IC50 values below 5 μM against the SKOV3 cell line. It should be noted that the cytotoxicities observed for the new gold(I) complexes are higher than those observed for phosphine sulphide ligands before binding to gold. Furthermore, the results also indicate that the presence of a nitrogenated heterocycle, such as tetrahydroquinoline or quinoline, is also necessary for the TopI inhibition to be maintained. In addition, no toxicity was observed when the non-cancerous lung fibroblast cell line (MRC5) was treated with the new phosphine sulphide gold(I) complexes prepared.

Graphical abstract: Novel phosphine sulphide gold(i) complexes: topoisomerase I inhibitors and antiproliferative agents

Back to tab navigation

Supplementary files

Article information


Submitted
21 Apr 2020
Accepted
15 May 2020
First published
20 May 2020

Dalton Trans., 2020, Advance Article
Article type
Paper

Novel phosphine sulphide gold(I) complexes: topoisomerase I inhibitors and antiproliferative agents

E. Martín-Encinas, V. Conejo-Rodríguez, J. A. Miguel, J. M. Martínez-Ilarduya, G. Rubiales, B. R. Knudsen, F. Palacios and C. Alonso, Dalton Trans., 2020, Advance Article , DOI: 10.1039/D0DT01467B

Social activity

Search articles by author

Spotlight

Advertisements